MATINAS BIOPHARMA HOLDINGS, INC. Adjustments to Additional Paid in Capital, Other
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Adjustments to Additional Paid in Capital, Other of $6.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, other for the quarter ending 2025-06-30 was $6.10M.
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2025 was $6.10M.
- MATINAS BIOPHARMA HOLDINGS, INC. adjustments to additional paid in capital, other for fiscal 2015 was $753.35K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|
| 2025-12-31 | $6.10M 10-K · filed 2026-03-31 | ||
| 2025-06-30 | $6.10M 10-Q · filed 2026-08-13 | $6.10M 10-Q · filed 2026-08-13 | |
| 2015-12-31 | $753.35K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |